Cryo Cell International (CCEL) Change in Accured Expenses (2010 - 2026)

Cryo Cell International (CCEL) has 17 years of Change in Accured Expenses data on file, last reported at -$1.4 million in Q1 2026.

• Change in Accured Expenses for Q1 2026 came in at -$1.4 million, up 5.59% year-over-year; the trailing twelve-month figure through Feb 2026 was -$1.4 million (down 569.97% YoY), and the FY2025 annual result was -$1.5 million, down 54926.23% from the prior year.
• Change in Accured Expenses declined to -$1.4 million in Q1 2026 per CCEL's latest filing, from $2.0 million in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $3.4 million in Q4 2023 and troughed at -$2.5 million in Q3 2024.
• A 5-year average of -$47597.6 and a median of -$445135.0 in 2023 frame the typical range for Change in Accured Expenses.
• The sharpest annual moves came in 2022 and 2023: Change in Accured Expenses soared 708.73% in 2022, then slumped 2862.7% in 2023.
• A 5-year view of Change in Accured Expenses shows it stood at $1.4 million in 2022, then surged by 142.47% to $3.4 million in 2023, then slipped by 26.6% to $2.5 million in 2024, then dropped by 20.04% to $2.0 million in 2025, then plunged by 169.76% to -$1.4 million in 2026.
• Business Quant data shows CCEL's Change in Accured Expenses at -$1.4 million in Q1 2026, $2.0 million in Q4 2025, and -$389123.0 in Q3 2025.